22100_11th Annual MCW Pancreatic Cancer Symposium Evaluation

0

Did you attend the Medical College of Wisconsin's 11th Annual Pancreatic Cancer Virtual Symposium (1/28/2022)?

Yes

No

First Name *

Last Name *

E-Mail *

Please fill in your Ethos login E-mail

1

Why did you attend this symposium?

To fulfill a personal learning objective

Department attendance requirement

To exchange information with other health professionals (e.g., a colleague)

To manage aspects of patient care with my care team

To address a clinical question (problem) regarding a specific patient

2

This symposium met the stated objectives

Yes

No

3

Please evaluate the following speaker presentations.

	Poor	Fair	Good	Very Good	Excellent
Mandana Kamgar, MD, MPH: GI Asco Update	Mandana Kamgar, MD, MPH: GI Asco Update - Poor	Mandana Kamgar, MD, MPH: GI Asco Update - Fair	Mandana Kamgar, MD, MPH: GI Asco Update - Good	Mandana Kamgar, MD, MPH: GI Asco Update - Very Good	Mandana Kamgar, MD, MPH: GI Asco Update - Excellent
Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time	Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time - Poor	Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time - Fair	Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time - Good	Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time - Very Good	Peter Hosein, MD: Making Inroads Into Pancreatic Cancer, One Subgroup At a Time - Excellent
Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions	Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions - Poor	Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions - Fair	Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions - Good	Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions - Very Good	Geertjan van Tienhoven, MD, PhD: Neoadjuvant chemoradiation for resectable pancreatic cancer; PREOPANC and future directions - Excellent
Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer	Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer - Poor	Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer - Fair	Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer - Good	Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer - Very Good	Jen Jen Yeh, MD: Molecular Subtypes of Pancreatic Cancer - Excellent
Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer	Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer - Poor	Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer - Fair	Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer - Good	Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer - Very Good	Bassel F. El-Rayes, MD: Targeting the stroma and immune system in pancreatic cancer - Excellent
Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence	Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence - Poor	Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence - Fair	Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence - Good	Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence - Very Good	Nigel B. Jamieson, MBChB, BSc (Hons), PhD: Unravelling molecular subtypes of pancreatic cancer recurrence - Excellent
Kathleen Christians, MD: Surgery for Locally Advanced PDAC	Kathleen Christians, MD: Surgery for Locally Advanced PDAC - Poor	Kathleen Christians, MD: Surgery for Locally Advanced PDAC - Fair	Kathleen Christians, MD: Surgery for Locally Advanced PDAC - Good	Kathleen Christians, MD: Surgery for Locally Advanced PDAC - Very Good	Kathleen Christians, MD: Surgery for Locally Advanced PDAC - Excellent

4

What is the impact of this information on you or your practice?

I learned something new

This information confirmed I did (am doing) the right thing

I am reminded of something I already knew

5

Did you (will you) use this information for a specific patient?

Yes

No

Possibly

5_1

If Yes, please check all that apply.

As a result of this information, I will manage this patient differently

I had several options for this patient and I will use this information to justify a choice

I will use this information in a discussion with this patient, or with other health professionals about this patient

6

This symposium was free of commercial bias.

Yes

No

If no, please explain.

6 If no, please explain.

7

Would you attend this symposium next year?

Yes

No

If no, please explain.

7 If no, please explain.

8

Do you have any suggested topics for future meetings?

9

Comments or suggestions for improvement?

You are here

22100_11th Annual MCW Pancreatic Cancer Symposium Evaluation